Skip to main content

2021 High Cost Drug Notices October-December 2021

11-22-2021_Letter to Vermont Notifying & Reporting New Drugs

11-24-2021_Letter to Vermont Notifying & Reporting New Drugs

argenx_Vermont_VYVGART_3-Day_Notice

AstraZeneca Pricing Transparency Notification

B Braun Medical Inc – VT Notice of New High Cost Drug 00264-4204-52

B Braun Medical Inc – VT Notice of New High Cost Drug 00264-4400-54

BioMarin – Vermont Voxzogo 3-Day Notice

Calcitonin Inj – Vermont State Notification (revised November 10 2021)

CLINDAMYCIN_ VT New Drug Notice

CLINDAMYCIN_75 VT New Drug Report

Drug Price Transparency – 3 Day Notice – VT Template_Carmustine_DRL

Drug Price Transparency – 3 Day Notice – VT_Daptomycin 350_DRL

Endo_Vermont 30-Day Notice Template Calcitonin

Endo_Vermont 30-Day Notice Template Micafungin_Final

Everolimus MPI VT Notice 10-04-21

Everolimus VT 30 Day MPI – 10-29-21

Gilead Sciences Inc. – VT Act 193 – New Drug Notice – EPCLUSA Oral Pellets

Gilead Sciences Inc. – VT Act 193 – New Drug Report – EPCLUSA Oral Pellets

Isosorbide Dinitrate Tablets – Vermont State Notification (revised December 13 2021)

Isosulfan Blue Injection 1% New Drug Report 12.3.2021

Isotretinoin 30 day notice VT 10_20_30MG

Letter to Office of Attorney General_New Drug Report Email – Azathioprine 75mg

Micafungin Inj – Vermont State Notification (revised October 25 2021)

Naprox-Esomep Mag MPI 3-day VT Notice

Naprox-Esomep MPI VT 30 Day 12-22-21

New Drug Report Cyclo 2gm 12.22

New Product- 3 days notice Epic PharmaLLC-12.27.2021

Notice of a New Prescription Drug Pursuant to 18 V.S.A § 4637(c) – Daptomycin

OBU VT New Drug Report – Exkivity – 20211020

Par_Vermont 30-Day Notice Template Varenicline_Final

Please_DocuSign_ADS_IT_Purchase_Request_and_ (1)

Please_DocuSign_ADS_IT_Purchase_Request_and_

Semglee VT 30 Day Report 12-15-21

Takeda-Livtencity-Vermont-New-Drug-Notice-20211124

TIVDAK_ VT New Drug Report

Vermont – Biocon – Everolimus Tablets

Vermont – StrataGraft new drug filing

Vermont 3-day launch notice_FINAL

Vermont Disclosure Notice

Vermont SDPT 30 Day Notification

Vermont WAC Reporting – Azathioprine Tablets 10.14.2021

Vermont WAC Reporting – Fluphenazine Tablets 500ct 10.26.2021

Vermont WAC Reporting – Nelarabine Inj 11.19.2021

Vermont WAC Reporting – Phytonadione 5mg 30 Count Tabs 12.14.2021

VT 30 Day Launch Notice- Ascendis (Skytrofa)

VT Act 193 New Drug Notice – Follistim, Maxalt, Ontruzant, Pregnyl, Renflexis

VT Act 193 New Drug Notice – Opzelura

VT Act 193 New Drug Notice

VT Act 193 New Drug Report – Maxalt, Ontruzant, Renflexis

VT Act 193 New Drug Report – Opzelura

VT New Drug Notice 3 Day- SUSVIMO Vial only

VT New Drug Notice 3 Day- SUSVIMO

VT New Drug Pricing Report -Bexarotene

VT New Drug Report – Argatroban

VT New Drug Report – Livtencity

VT New Drug Reporting 30 Day-SUSVIMO Vial Only

VT New Drug Reporting 30 Day-SUSVIMO

VT New Drug_Argatroban_10_08_2021

VT New Drug_Everolimus_12_02_2021

VT New Prescription Drug Notice_2021.10.20

VT New Prescrition Drug 30-day Notice_2021.11.18

VT Notice of Introduction of New High-Cost Prescription Drugs – Leqvio

VT Notice of New Drug Introduction – Erlotinib HCL

VT Notice of New Drug Introduction – Pyrimethamine Tabs

VT Notice of New Prescription Drug Report – XIPERE

VT Report for LYBALVI

VT Report of Introduction of New High-Cost Prescription Drugs – SCEMBLIX

VT_11_NewDrugReport_20210223

VT_11_NewDrugReport_20211201

VT_11_NewDrugReport_20211231